BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Prognosis
27 results:

  • 1. Ectopic pheochromocytomas in the third trimester: A case report and literature review.
    Zhao L; Chen M; Chen X; Yu L; Du SG; Gan Q; Yang WZ; Jiang C; Xiao M
    Medicine (Baltimore); 2024 Feb; 103(5):e36127. PubMed ID: 38306535
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tumour microenvironment in pheochromocytoma and paraganglioma.
    Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E
    Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
    Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bladder paraganglioma: basic characteristics and new perspectives on perioperative management.
    Cai T; Lu J; Lin Z; Luo M; Liang H; Qin Z; Ye Y
    World J Urol; 2022 Nov; 40(11):2807-2816. PubMed ID: 36205740
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long Noncoding RNA LOC554202 Predicts a Poor prognosis and Correlates with Immune Infiltration in Thyroid cancer.
    Chen C; Qin L; Xiao MF
    Comput Math Methods Med; 2022; 2022():3585626. PubMed ID: 35265169
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [endocrine and neuroendocrine tumors].
    Riss P; Scheuba K; Strobel O
    Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience.
    De Filpo G; Cantini G; Rastrelli G; Vannini G; Ercolino T; Luconi M; Mannelli M; Maggi M; Canu L
    J Endocrinol Invest; 2022 Jan; 45(1):149-157. PubMed ID: 34227051
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
    Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
    Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma.
    Kim JH; Kim MJ; Kong SH; Kim SJ; Kang H; Shin CS; Park SS; Lee KE; Seong MW
    J Med Genet; 2022 Jan; 59(1):56-64. PubMed ID: 33219105
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. New Insights into Pheochromocytoma Biology: the Role of the Insulin - Like Growth Factor 1 (IGF1) System.
    Pennisi PA; Fernández MC; Martin A
    Pediatr Endocrinol Rev; 2020 Aug; 17(4):331-342. PubMed ID: 32780957
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.
    Jochmanova I; Abcede AMT; Guerrero RJS; Malong CLP; Wesley R; Huynh T; Gonzales MK; Wolf KI; Jha A; Knue M; Prodanov T; Nilubol N; Mercado-Asis LB; Stratakis CA; Pacak K
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1051-1063. PubMed ID: 32062700
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
    Mei L; Khurana A; Al-Juhaishi T; Faber A; Celi F; Smith S; Boikos S
    Horm Metab Res; 2019 Jul; 51(7):451-457. PubMed ID: 30919391
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
    Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
    Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome.
    Därr R; Nambuba J; Del Rivero J; Janssen I; Merino M; Todorovic M; Balint B; Jochmanova I; Prchal JT; Lechan RM; Tischler AS; Popovic V; Miljic D; Adams KT; Prall FR; Ling A; Golomb MR; Ferguson M; Nilubol N; Chen CC; Chew E; Taïeb D; Stratakis CA; Fojo T; Yang C; Kebebew E; Zhuang Z; Pacak K
    Endocr Relat Cancer; 2016 Dec; 23(12):899-908. PubMed ID: 27679736
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.
    Blanchet EM; Taieb D; Millo C; Martucci V; Chen CC; Merino M; Herscovitch P; Pacak K
    J Nucl Med; 2015 Dec; 56(12):1849-54. PubMed ID: 26359261
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.
    Ramachandran R; Bech P; Murphy KG; Caplin ME; Patel M; Vohra S; Khan MS; Dhillo WS; Sharma R; Palazzo FF; Win Z; Tan T; Khoo B; Meeran K; Frilling A; Ghatei MA; Bloom SR; Martin NM
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1520-8. PubMed ID: 25664601
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Peritoneal implantation of pheochromocytoma following tumor capsule rupture during surgery.
    Rafat C; Zinzindohoue F; Hernigou A; Hignette C; Favier J; Tenenbaum F; Gimenez-Roqueplo AP; Plouin PF; Amar L
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2681-5. PubMed ID: 25188716
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. MicroRNA-21 identified as predictor of cancer outcome: a meta-analysis.
    Zhu W; Xu B
    PLoS One; 2014; 9(8):e103373. PubMed ID: 25098165
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long-term prognosis of patients with pediatric pheochromocytoma.
    Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
    Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
    Ayala-Ramirez M; Chougnet CN; Habra MA; Palmer JL; Leboulleux S; Cabanillas ME; Caramella C; Anderson P; Al Ghuzlan A; Waguespack SG; Deandreis D; Baudin E; Jimenez C
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4040-50. PubMed ID: 22965939
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.